In a previous study, we analyzed mutations in the mitochondrial NADH dehydrogenase subunit 1 (MT-ND1) gene to determine their associations with clinicopathological parameters and postoperative recurrence of RCC in 62 Japanese patients [12]. This evidence concerns the gene MT-ND1 and renal cell carcinoma.